Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Brickell Biotech, Inc. (BBI)

0.1863   -0.021 (-9.96%) 05-16 08:29
Open: 0.19 Pre. Close: 0.2069
High: 0.21 Low: 0.185
Volume: 5,864,055 Market Cap: 22(M)
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.21 - 0.21 0.21 - 0.21
Low: 0.18 - 0.18 0.18 - 0.18
Close: 0.18 - 0.19 0.19 - 0.19

Technical analysis

as of: 2022-05-16 8:16:47 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.38     One year: 0.49
Support: Support1: 0.18    Support2: 0.15
Resistance: Resistance1: 0.33    Resistance2: 0.41
Pivot: 0.22
Moving Average: MA(5): 0.19     MA(20): 0.24
MA(100): 0.24     MA(250): 0.47
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 4.1     %D(3): 4.3
RSI: RSI(14): 37.5
52-week: High: 1.03  Low: 0.18
Average Vol(K): 3-Month: 5,593 (K)  10-Days: 8,011 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ BBI ] has closed above bottom band by 7.7%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 16 May 2022
-$0.05 EPS Expected for Brickell Biotech, Inc. (NASDAQ:BBI) This Quarter - Defense World

Sat, 14 May 2022
1981 Ferrari 512 BBI "Koenig Specials" For Sale - HYPEBEAST

Thu, 12 May 2022
Brickell (BBI) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq

Thu, 12 May 2022
Ruto-Musalia deal akin to BBI, says Azimio - The Standard

Wed, 11 May 2022
Colloidal Gold Market Size 2022 Analysis by 2029 | Key Players – BBI Solutions, Cline Scientific, Cytodiagnostics, Goldsol, Meliorum Technologies – Queen Anne and Mangolia News - Queen Anne and Mangolia News

Wed, 04 May 2022
BigBoys Industry (BBI) Up 1.03% Wednesday: What's Next? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 115 (M)
% Held by Insiders 1.0743e+008 (%)
% Held by Institutions 1.2 (%)
Shares Short 1,890 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -4.132e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -12
Return on Assets (ttm) 642.2
Return on Equity (ttm) -102.2
Qtrly Rev. Growth 327000
Gross Profit (p.s.) -175
Sales Per Share -5270.5
EBITDA (p.s.) -2.3475e+008
Qtrly Earnings Growth -0.7
Operating Cash Flow 0 (M)
Levered Free Cash Flow -36 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.03

Stock Dividends

Dividend 0
Forward Dividend 1.88e+006
Dividend Yield 0%
Dividend Pay Date 2019-09-02
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.